Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Issued New United States Patent, Extending the Broadest Natural Psilocybin Patent Estate

Go back to Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Issued New United States Patent, Extending the Broadest Natural Psilocybin Patent Estate
(AMEX: TRUFF) Delayed: 0.02 --0 (-0%)
Previous Close $0.02    52 Week High
Open $0.03    52 Week Low
Day High $0.03    P/E N/A 
Day Low $0.02    EPS
Volume 18,065